SCHEMBL27420432

SCHEMBL27420432

C=C1N(C2CC2)CCN1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24952523 0.75 POLB (0.32) —
SCHEMBL21946652 0.69 — —
SCHEMBL8242236 0.67 — —
SCHEMBL24974463 0.66 — —
SCHEMBL15688479 0.60 — —
SCHEMBL20710022 0.59 — —
SCHEMBL15688368 0.58 LMNA (0.31) —
SCHEMBL15030921 0.58 — —
SCHEMBL14682741 0.58 — —
SCHEMBL15688678 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217952-A1 TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN POSEIDON INNOVATION 1, INC. 2024-07-04 — — US disclosed
Send feedback